Methylphenidate and Dyslipidemia

Codice QR

Methylphenidate and Dyslipidemia

None

Salvato in:

Dettagli Bibliografici
Autori principali:	Charach, Gideon, Kaysar, Nechemia, Rabinovich, Alexander, Argov, Ori, Weintraub, Moshe
Natura:	Elettronico Capitolo di libro
Lingua:	inglese
Pubblicazione:	IntechOpen 2012
Soggetti:	Health Sciences
Accesso online:	https://www.intechopen.com/chapters/28247
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Nutrigenetics and Dyslipidemia
di: Shalileh, Maryam
Pubblicazione: (2012)

Dyslipidemia and Cardiovascular Disease
di: Fakhrzadeh, Hossein, et al.
Pubblicazione: (2012)

Dyslipidemia and Mental Illness
di: Saravane, D.
Pubblicazione: (2012)

Dyslipidemia Induced by Stress
di: Marcondes, Fernanda Klein, et al.
Pubblicazione: (2012)

Dyslipidemia: Genetics and Role in the Metabolic Syndrome
di: Nock, Nora L., et al.
Pubblicazione: (2012)

Dyslipidemia in Patients with Lipodystrophy in the Use of Antiretroviral Therapy
di: Libonati, Rosana, et al.
Pubblicazione: (2012)

Functions of OSBP/ORP Family Proteins and Their Relation to Dyslipidemia
di: Koriyama, Hiroshi, et al.
Pubblicazione: (2012)

Impact of Climate Change and Air Pollution on Dyslipidemia and the Components of Metabolic Syndrome
di: Kelishadi, Roya, et al.
Pubblicazione: (2012)

Dyslipidemia and Cardiovascular Risk: Lipid Ratios as Risk Factors for Cardiovascular Disease
di: Pereira, Telmo
Pubblicazione: (2012)

Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease
di: Huri, Hasniza Zaman
Pubblicazione: (2012)

Changes in behavior as side effects in methylphenidate treatment: review of the literature
di: Konrad-Bindl DS, et al.
Pubblicazione: (2016-10-01)

Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia
di: Barroso, Emma, et al.
Pubblicazione: (2012)

Novel hematologic ratios and systemic inflammation index in ADHD: effects of methylphenidate treatment
di: Meryem Kaşak, et al.
Pubblicazione: (2025-07-01)

Testosterone for the Treatment of Mammary and Prostate Cancers: Historical Perspectives and New Directions
di: Rogosnitzky, Moshe, et al.
Pubblicazione: (2012)

Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis.
di: Shun Gong, et al.
Pubblicazione: (2014-01-01)

The Effect of Methylphenidate on The Consciousness Level of Intoxicated Patients; a Double-Blind Clinical Trial
di: Faraz Zandiyeh, et al.
Pubblicazione: (2025-06-01)

Seroprevalence of Human Immunodeficiency Virus (HIV) Among Blood Donors in Jos - Nigeria
di: Julie, Egesie, et al.
Pubblicazione: (2011)

Pacemaker and Network Mechanisms of Neural Rhythm Generation
di: Nowotny, Thomas, et al.
Pubblicazione: (2011)

The Physiology and the Clinical Significance of Postoperative Hyperlactatemia After Pediatric Cardiac Surgery
di: Molina-Hazan, Vered, et al.
Pubblicazione: (2012)

Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial
di: Patrick Stone, et al.
Pubblicazione: (2025-07-01)

Effect of Short-Term Exposure to Near Highway Pollutants in Motor Vehicle Exhaust on Inflammation Sensitive Biomarkers
di: Rogowski, Ori, et al.
Pubblicazione: (2011)

The 18 kDa Translocator Protein as a Potential Participant in Atherosclerosis
di: Dimitrova-Shumkovska, Jasmina, et al.
Pubblicazione: (2012)

DYSLIPIDEMIA FEATURES IN CHILDREN
di: T. I. Turkinа, et al.
Pubblicazione: (2016-01-01)

Methylphenidate or Family Mindfulness? Effects on Internalizing, Externalizing and Social Problems in Children with Attention Deficit Hyperactivity Disorder
di: Brett Kosterman Zoller, et al.
Pubblicazione: (2025-05-01)

Surgical Management of Atrial Fibrillation
di: Yanagawa, Bobby, et al.
Pubblicazione: (2012)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
di: Huss M, et al.
Pubblicazione: (2016-05-01)

Illuminating Hidden Features of Stem Cells
di: Grafi, Gideon, et al.
Pubblicazione: (2011)

New methods for dyslipidemia correction
di: V. T. Ivashkin, et al.
Pubblicazione: (1970-01-01)

Effect of Fruit and Vegetable Intake on Oxidative Stress and Dyslipidemia Markers in Human and Animal Models
di: Domínguez-Avila, Jesús Abraham, et al.
Pubblicazione: (2011)

Assisted Reproduction and Preterm Birth
di: Erez, Offer, et al.
Pubblicazione: (2012)

Dyslipidemia in Critical Conditions of Various Etiology
di: L. N. Shcherbakova, et al.
Pubblicazione: (2008-02-01)

Aorta and brachiocephalic artery pathology in dyslipidemia
di: B. M. Lipovetsky
Pubblicazione: (2005-06-01)

DYSLIPIDEMIA ROLE IN THE DEVELOPMENT OF METABOLIC SYNDROME
di: M. V. Antonyuk, et al.
Pubblicazione: (2011-10-01)

The role of constipation in the development of dyslipidemia in the elderly
di: A. V. Martynenko, et al.
Pubblicazione: (2025-06-01)

Abdominal Obesity, Dyslipidemia and Blood Pressure
di: Pedro Enrique Miguel Soca
Pubblicazione: (2015-11-01)

The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients
di: Başay, et al.
Pubblicazione: (2016-05-01)

Increased Recall of Negative Memories Following Initial Methylphenidate Administration in a 6‐Year‐Old Boy With ADHD: A Case Report
di: Qingqing Xiang, et al.
Pubblicazione: (2025-06-01)

ANALYSIS OF THE INTERACTION OF LIPID METABOLISM ALLELES IN DYSLIPIDEMIA
di: I. V. Nikolaev, et al.
Pubblicazione: (2015-01-01)

Effective polypill therapy in patients with hypertension and dyslipidemia
di: V. E. Oleynikov, et al.
Pubblicazione: (2025-07-01)

Significance of dyslipidemia for primary open-angle glaucoma
di: C. Erb, et al.
Pubblicazione: (2022-09-01)